Skip to main content

Advertisement

SpringerLink
Log in

Pathological fractures in paediatric patients with inflammatory bowel disease

  • Review
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Paediatric inflammatory bowel disease (IBD), especially Crohn’s disease (CD), is commonly associated with poor skeletal health, related to the direct effects of chronic inflammation, prolonged use of glucocorticoid (GC), poor nutrition, delayed puberty and low muscle mass. Low bone mineral density is commonly reported, although the prevalence of long bone fractures may not be increased in these patients. Emerging evidence however suggests that there may be an increased risk of vertebral fractures (VFs) in this group. VFs presenting at diagnosis of paediatric CD, prior to any GC exposure, have been reported, highlighting the deleterious effect of inflammation on skeletal health. This paper reviews the published literature on pathophysiology of skeletal morbidity and fractures in paediatric IBD, illustrated with a new case report of multiple VFs in a prepubertal girl with CD, soon after diagnosis, who received minimal amounts of oral GC. Optimising control of disease, addressing vitamin D deficiency, encouraging physical activity and ensuring normal growth and pubertal progression are paramount to management of bone health in these patients. Despite the lack of evidence, there may be a place for bisphosphonate treatment, especially in the presence of symptomatic pathological fractures, but this requires close monitoring by clinicians with expertise in paediatric bone health. Conclusion: Chronic inflammation mediated by pro-inflammatory cytokines may have adverse effects on skeletal health in paediatric patients with IBD. The risk of vertebral fractures may be increased, even without exposure to glucocorticoid. Clinical monitoring of these patients requires careful attention to the various factors that impact on bone health.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Abu-Amer Y, Ross FP, Edwards J, Teitelbaum SL (1997) Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. J Clin Invest 100:1557–1565

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Ahmed SF, Russell S, Rashid R, Beattie TJ, Murphy AV, Ramage IJ, Maxwell H (2004) Bone mineral assessment in children with inflammatory bowel disease: evaluation by age or bone area. J Pediatr Gastroenterol Nutr 38:276–280

    Article  CAS  PubMed  Google Scholar 

  3. Baim S, Leonard MB, Bianchi ML, Hans DB, Kalkwarf HJ, Langman CB, Rauch F (2008) Official positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference. J Clin Densitom 11:6–21

    Article  PubMed  Google Scholar 

  4. Ballinger AB, Savage MO, Sanderson IR (2003) Delayed puberty associated with inflammatory bowel disease. Pediatr Res 53:205–210

    Article  PubMed  Google Scholar 

  5. Batch JA, Couper JJ, Rodda C, Cowell CT, Zacharin M (2003) Use of bisphosphonate therapy for osteoporosis in childhood and adolescence. J Paediatr Child Health 39:88–92

    Article  CAS  PubMed  Google Scholar 

  6. Beattie RM, Camacho-Hubner C, Wacharasindhu S, Cotterill AM, Walker-Smith JA, Savage MO (1998) Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Crohn’s disease. Clin Endocrinol (Oxf) 49:483–489

    Article  CAS  Google Scholar 

  7. Benchimol EI, Ward LM, Gallagher JC, Rauch F, Barrowman N, Warren J, Beedle S, Mack DR (2007) Effect of calcium and vitamin D supplementation on bone mineral density in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 45:538–545

    Article  CAS  PubMed  Google Scholar 

  8. Bernstein M, Irwin S, Greenberg GR (2005) Maintenance infliximab treatment is associated with improved bone mineral density in Crohn’s disease. Am J Gastroenterol 100:2031–2035

    Article  CAS  PubMed  Google Scholar 

  9. Bonjour JP, Chevalley T, Ferrari S, Rizzoli R (2009) The importance and relevance of peak bone mass in the prevalence of osteoporosis. Salud Publica Mex 51(Suppl 1):S5–S17

    PubMed  Google Scholar 

  10. Boot AM, Bouquet J, Krenning EP, de Muinck Keizer-Schrama SM (1998) Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut 42:188–194

    Article  CAS  PubMed  Google Scholar 

  11. Burnham JM, Shults J, Semeao E, Foster B, Zemel BS, Stallings VA, Leonard MB (2004) Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition. J Bone Miner Res 19:1961–1968

    Article  PubMed  Google Scholar 

  12. Clark EM, Ness AR, Bishop NJ, Tobias JH (2006) Association between bone mass and fractures in children: a prospective cohort study. J Bone Miner Res 21:1489–1495

    Article  PubMed Central  PubMed  Google Scholar 

  13. Clark EM, Tobias JH, Ness AR (2006) Association between bone density and fractures in children: a systematic review and meta-analysis. Pediatrics 117:e291–e297

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Clowes GH, Jr., George BC, Villee CA, Jr., Saravis CA (1983) Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. N Engl J Med 308:545–552

    Google Scholar 

  15. Cooper MS, Bujalska I, Rabbitt E, Walker EA, Bland R, Sheppard MC, Hewison M, Stewart PM (2001) Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation. J Bone Miner Res 16:1037–1044

    Article  CAS  PubMed  Google Scholar 

  16. Cooper MS, Rabbitt EH, Goddard PE, Bartlett WA, Hewison M, Stewart PM (2002) Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure. J Bone Miner Res 17:979–986

    Article  CAS  PubMed  Google Scholar 

  17. Cowan FJ, Parker DR, Jenkins HR (1995) Osteopenia in Crohn’s disease. Arch Dis Child 73:255–256

    Article  CAS  PubMed  Google Scholar 

  18. Crabtree NJ, Hogler W, Cooper MS, Shaw NJ (2013) Diagnostic evaluation of bone densitometric size adjustment techniques in children with and without low trauma fractures. Osteoporos Int 24:2015–2024

    Article  CAS  PubMed  Google Scholar 

  19. Crabtree NJ, Kibirige MS, Fordham JN, Banks LM, Muntoni F, Chinn D, Boivin CM, Shaw NJ (2004) The relationship between lean body mass and bone mineral content in paediatric health and disease. Bone 35:965–972

    Article  CAS  PubMed  Google Scholar 

  20. Critch J, Day AS, Otley A, King-Moore C, Teitelbaum JE, Shashidhar H (2012) Use of enteral nutrition for the control of intestinal inflammation in pediatric Crohn disease. J Pediatr Gastroenterol Nutr 54:298–305

    Article  PubMed  Google Scholar 

  21. Deboer MD, Li Y (2011) Puberty is delayed in male mice with dextran sodium sulfate colitis out of proportion to changes in food intake, body weight, and serum levels of leptin. Pediatr Res 69:34–39

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. DeBoer MD, Li Y, Cohn S (2010) Colitis causes delay in puberty in female mice out of proportion to changes in leptin and corticosterone. J Gastroenterol 45:277–284

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Duan Y, Turner CH, Kim BT, Seeman E (2001) Sexual dimorphism in vertebral fragility is more the result of gender differences in age-related bone gain than bone loss. J Bone Miner Res 16:2267–2275

    Article  CAS  PubMed  Google Scholar 

  24. Dubner SE, Shults J, Baldassano RN, Zemel BS, Thayu M, Burnham JM, Herskovitz RM, Howard KM, Leonard MB (2009) Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn’s disease. Gastroenterology 136:123–130

    Article  PubMed Central  PubMed  Google Scholar 

  25. Dziechciarz P, Horvath A, Shamir R, Szajewska H (2007) Meta-analysis: enteral nutrition in active Crohn’s disease in children. Aliment Pharmacol Ther 26:795–806

    Article  CAS  PubMed  Google Scholar 

  26. El-Hodhod MA, Hamdy AM, Abbas AA, Moftah SG, Ramadan AA (2012) Fibroblast growth factor 23 contributes to diminished bone mineral density in childhood inflammatory bowel disease. BMC gastroenterol 12:44

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. El-Matary W, Sikora S, Spady D (2011) Bone mineral density, vitamin D, and disease activity in children newly diagnosed with inflammatory bowel disease. Dig Dis Sci 56:825–829

    Article  CAS  PubMed  Google Scholar 

  28. Feagan BG, Lemann M, Befrits R, Connell W, D’Haens G, Ghosh S, Michetti P, Ochsenkuhn T, Panaccione R, Schreiber S, Silverberg M, Sorrentino D, van der Woude CJ, Vermeire S, Rutgeerts P (2012) Recommendations for the treatment of Crohn’s disease with tumor necrosis factor antagonists: an expert consensus report. Inflamm Bowel Dis 18:152–160

    Article  PubMed  Google Scholar 

  29. Ferreira R, Almeida S (2010) Crohn’s disease in a child: unusual presentation with severe osteoporosis. BioDrugs 24(Suppl 1):31–33

    Article  PubMed  Google Scholar 

  30. Fewtrell MS (2003) Bone densitometry in children assessed by dual X ray absorptiometry: uses and pitfalls. Arch Dis Child 88:795–798

    Article  CAS  PubMed  Google Scholar 

  31. Fewtrell MS, Gordon I, Biassoni L, Cole TJ (2005) Dual X-ray absorptiometry (DXA) of the lumbar spine in a clinical paediatric setting: does the method of size-adjustment matter? Bone 37:413–419

    Article  CAS  PubMed  Google Scholar 

  32. Gilbert LC, Rubin J, Nanes MS (2005) The p55 TNF receptor mediates TNF inhibition of osteoblast differentiation independently of apoptosis. Am J Physiol Endocrinol Metab 288:E1011–E1018

    Article  CAS  PubMed  Google Scholar 

  33. Gokhale R, Favus MJ, Karrison T, Sutton MM, Rich B, Kirschner BS (1998) Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology 114:902–911

    Article  CAS  PubMed  Google Scholar 

  34. Gordon CM, Bachrach LK, Carpenter TO, Crabtree N, El-Hajj Fuleihan G, Kutilek S, Lorenc RS, Tosi LL, Ward KA, Ward LM, Kalkwarf HJ (2008) Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 ISCD Pediatric Official Positions. J Clin Densitom 11:43–58

    Article  PubMed  Google Scholar 

  35. Guttridge DC, Mayo MW, Madrid LV, Wang CY, Baldwin AS Jr (2000) NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289:2363–2366

    Article  CAS  PubMed  Google Scholar 

  36. Hahn TJ, Halstead LR, Teitelbaum SL, Hahn BH (1979) Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration. J Clin Invest 64:655–665

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  37. Henry YM, Fatayerji D, Eastell R (2004) Attainment of peak bone mass at the lumbar spine, femoral neck and radius in men and women: relative contributions of bone size and volumetric bone mineral density. Osteoporos Int 15:263–273

    Article  PubMed  Google Scholar 

  38. Herzog D, Bishop N, Glorieux F, Seidman EG (1998) Interpretation of bone mineral density values in pediatric Crohn’s disease. Inflamm Bowel Dis 4:261–267

    Google Scholar 

  39. Hill RJ, Brookes DS, Lewindon PJ, Withers GD, Ee LC, Connor FL, Cleghorn GJ, Davies PS (2009) Bone health in children with inflammatory bowel disease: adjusting for bone age. J Pediatr Gastroenterol Nutr 48:538–543

    Article  PubMed  Google Scholar 

  40. Hofbauer LC, Gori F, Riggs BL, Lacey DL, Dunstan CR, Spelsberg TC, Khosla S (1999) Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140:4382–4389

    CAS  PubMed  Google Scholar 

  41. Huber AM, Gaboury I, Cabral DA, Lang B, Ni A, Stephure D, Taback S, Dent P, Ellsworth J, LeBlanc C, Saint-Cyr C, Scuccimarri R, Hay J, Lentle B, Matzinger M, Shenouda N, Moher D, Rauch F, Siminoski K, Ward LM, Canadian Steroid-Associated Osteoporosis in the Pediatric Population C (2010) Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders. Arthritis Care Res (Hoboken) 62:516–526

    Article  CAS  Google Scholar 

  42. Hyams JS, Wyzga N, Kreutzer DL, Justinich CJ, Gronowicz GA (1997) Alterations in bone metabolism in children with inflammatory bowel disease: an in vitro study. J Pediatr Gastroenterol Nutr 24:289–295

    Article  CAS  PubMed  Google Scholar 

  43. Irwin R, Lee T, Young VB, Parameswaran N, McCabe LR (2013) Colitis-induced bone loss is gender dependent and associated with increased inflammation. Inflamm Bowel Dis 19:1586–1597

    PubMed  Google Scholar 

  44. Kappelman MD, Galanko JA, Porter CQ, Sandler RS (2011) Risk of diagnosed fractures in children with inflammatory bowel diseases. Inflamm Bowel Dis 17:1125–1130

    Article  PubMed Central  PubMed  Google Scholar 

  45. Kaur K, Hardy R, Ahasan MM, Eijken M, van Leeuwen JP, Filer A, Thomas AM, Raza K, Buckley CD, Stewart PM, Rabbitt EH, Hewison M, Cooper MS (2010) Synergistic induction of local glucocorticoid generation by inflammatory cytokines and glucocorticoids: implications for inflammation associated bone loss. Ann Rheum Dis 69:1185–1190

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  46. Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T (2000) Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 191:275–286

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  47. Laakso S, Valta H, Verkasalo M, Toiviainen-Salo S, Viljakainen H, Makitie O (2012) Impaired bone health in inflammatory bowel disease: a case–control study in 80 pediatric patients. Calcif Tissue Int 91:121–130

    Article  CAS  PubMed  Google Scholar 

  48. Leonard MB, Shults J, Elliott DM, Stallings VA, Zemel BS (2004) Interpretation of whole body dual energy X-ray absorptiometry measures in children: comparison with peripheral quantitative computed tomography. Bone 34:1044–1052

    Article  PubMed  Google Scholar 

  49. Liu XH, Kirschenbaum A, Yao S, Levine AC (2005) Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system. Endocrinology 146:1991–1998

    Article  CAS  PubMed  Google Scholar 

  50. Lopes LH, Sdepanian VL, Szejnfeld VL, de Morais MB, Fagundes-Neto U (2008) Risk factors for low bone mineral density in children and adolescents with inflammatory bowel disease. Dig Dis Sci 53:2746–2753

    Article  PubMed  Google Scholar 

  51. Lu PW, Briody JN, Ogle GD, Morley K, Humphries IR, Allen J, Howman-Giles R, Sillence D, Cowell CT (1994) Bone mineral density of total body, spine, and femoral neck in children and young adults: a cross-sectional and longitudinal study. J Bone Miner Res 9:1451–1458

    Article  CAS  PubMed  Google Scholar 

  52. Lucarelli S, Borrelli O, Paganelli M, Capocaccia P, Frediani T, Ferri F, Cucchiara S (2006) Vertebral fractures and increased sensitivity to corticosteroids in a child with ulcerative colitis: successful use of pamidronate. J Pediatr Gastroenterol Nutr 43:533–535

    Article  PubMed  Google Scholar 

  53. Ma K, Mallidis C, Bhasin S, Mahabadi V, Artaza J, Gonzalez-Cadavid N, Arias J, Salehian B (2003) Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab 285:E363–E371

    CAS  PubMed  Google Scholar 

  54. Mason A, Malik S, Russell RK, Bishop J, McGrogan P, Ahmed SF (2011) Impact of inflammatory bowel disease on pubertal growth. Horm Res Paediatr 76:293–299

    Article  CAS  PubMed  Google Scholar 

  55. Mauro M, Radovic V, Armstrong D (2007) Improvement of lumbar bone mass after infliximab therapy in Crohn’s disease patients. Can J Gastroenterol 21:637–642

    PubMed Central  PubMed  Google Scholar 

  56. Newby EA, Sawczenko A, Thomas AG, Wilson D (2005) Interventions for growth failure in childhood Crohn’s disease. Cochrane Database Syst Rev:CD003873

  57. Paganelli M, Albanese C, Borrelli O, Civitelli F, Canitano N, Viola F, Passariello R, Cucchiara S (2007) Inflammation is the main determinant of low bone mineral density in pediatric inflammatory bowel disease. Inflamm Bowel Dis 13:416–423

    Article  PubMed  Google Scholar 

  58. Pappa HM, Gordon CM, Saslowsky TM, Zholudev A, Horr B, Shih MC, Grand RJ (2006) Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 118:1950–1961

    Article  PubMed Central  PubMed  Google Scholar 

  59. Pappa HM, Grand RJ, Gordon CM (2006) Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm Bowel Dis 12:1162–1174

    Article  PubMed  Google Scholar 

  60. Pappa HM, Langereis EJ, Grand RJ, Gordon CM (2011) Prevalence and risk factors for hypovitaminosis D in young patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 53:361–364

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  61. Pappa HM, Mitchell PD, Jiang H, Kassiff S, Filip-Dhima R, DiFabio D, Quinn N, Lawton RC, Varvaris M, Van Straaten S, Gordon CM (2012) Treatment of vitamin D insufficiency in children and adolescents with inflammatory bowel disease: a randomized clinical trial comparing three regimens. J Clin Endocrinol Metab 97:2134–2142

    Article  CAS  PubMed  Google Scholar 

  62. Pappa H, Thayu M, Sylvester F, Leonard M, Zemel B, Gordon C (2011) Skeletal health of children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 53:11–25

    Article  PubMed Central  PubMed  Google Scholar 

  63. Pazianas M, Rhim AD, Weinberg AM, Su C, Lichtenstein GR (2006) The effect of anti-TNF-alpha therapy on spinal bone mineral density in patients with Crohn’s disease. Ann N Y Acad Sci 1068:543–556

    Article  CAS  PubMed  Google Scholar 

  64. Persad R, Jaffer I, Issenman RM (2006) The prevalence of long bone fractures in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 43:597–602

    Article  PubMed  Google Scholar 

  65. Rauch F, Plotkin H, DiMeglio L, Engelbert RH, Henderson RC, Munns C, Wenkert D, Zeitler P (2008) Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2007 Pediatric Official Positions. J Clin Densitom 11:22–28

    Article  PubMed  Google Scholar 

  66. Sanderson IR, Udeen S, Davies PS, Savage MO, Walker-Smith JA (1987) Remission induced by an elemental diet in small bowel Crohn’s disease. Arch Dis Child 62:123–127

    Article  CAS  PubMed  Google Scholar 

  67. Sarzi-Puttini P, Atzeni F, Scholmerich J, Cutolo M, Straub RH (2006) Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3. Ann Rheum Dis 65:301–305

    Article  CAS  PubMed  Google Scholar 

  68. Sbrocchi AM, Forget S, Laforte D, Azouz EM, Rodd C (2010) Zoledronic acid for the treatment of osteopenia in pediatric Crohn’s disease. Pediatr Int 52:754–761

    Article  CAS  PubMed  Google Scholar 

  69. Schoenau E (2005) From mechanostat theory to development of the “functional muscle-bone-unit”. J Musculoskelet Neuronal Interact 5:232–238

    CAS  PubMed  Google Scholar 

  70. Schoenau E, Neu CM, Mokov E, Wassmer G, Manz F (2000) Influence of puberty on muscle area and cortical bone area of the forearm in boys and girls. J Clin Endocrinol Metab 85:1095–1098

    CAS  PubMed  Google Scholar 

  71. Schoenau E, Neu CM, Rauch F, Manz F (2002) Gender-specific pubertal changes in volumetric cortical bone mineral density at the proximal radius. Bone 31:110–113

    Article  CAS  PubMed  Google Scholar 

  72. Seeman E (2001) Clinical review 137: sexual dimorphism in skeletal size, density, and strength. J Clin Endocrinol Metab 86:4576–4584

    CAS  PubMed  Google Scholar 

  73. Semeao EJ, Stallings VA, Peck SN, Piccoli DA (1997) Vertebral compression fractures in pediatric patients with Crohn’s disease. Gastroenterology 112:1710–1713

    Article  CAS  PubMed  Google Scholar 

  74. Sentongo TA, Semaeo EJ, Stettler N, Piccoli DA, Stallings VA, Zemel BS (2002) Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr 76:1077–1081

    CAS  PubMed  Google Scholar 

  75. Siggelkow H, Eidner T, Lehmann G, Viereck V, Raddatz D, Munzel U, Hein G, Hufner M (2003) Cytokines, osteoprotegerin, and RANKL in vitro and histomorphometric indices of bone turnover in patients with different bone diseases. J Bone Miner Res 18:529–538

    Article  CAS  PubMed  Google Scholar 

  76. Sylvester FA (2001) Bone abnormalities in gastrointestinal and hepatic disease. Rev Endocr Metab Disord 2:75–80

    Article  CAS  PubMed  Google Scholar 

  77. Sylvester FA, Davis PM, Wyzga N, Hyams JS, Lerer T (2006) Are activated T cells regulators of bone metabolism in children with Crohn disease? J Pediatr 148:461–466

    Article  CAS  PubMed  Google Scholar 

  78. Sylvester FA, Leopold S, Lincoln M, Hyams JS, Griffiths AM, Lerer T (2009) A two-year longitudinal study of persistent lean tissue deficits in children with Crohn’s disease. Clin Gastroenterol Hepatol 7:452–455

    Article  PubMed  Google Scholar 

  79. Sylvester FA, Wyzga N, Hyams JS, Davis PM, Lerer T, Vance K, Hawker G, Griffiths AM (2007) Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease. Inflamm Bowel Dis 13:42–50

    Article  PubMed  Google Scholar 

  80. Sylvester FA, Wyzga N, Hyams JS, Gronowicz GA (2002) Effect of Crohn’s disease on bone metabolism in vitro: a role for interleukin-6. J Bone Miner Res 17:695–702

    Article  CAS  PubMed  Google Scholar 

  81. Szulc P, Seeman E, Delmas PD (2000) Biochemical measurements of bone turnover in children and adolescents. Osteoporos Int 11:281–294

    Article  CAS  PubMed  Google Scholar 

  82. Taes Y, Lapauw B, Griet V, De Bacquer D, Goemaere S, Zmierczak H, Kaufman JM (2010) Prevalent fractures are related to cortical bone geometry in young healthy men at age of peak bone mass. J Bone Miner Res 25:1433–1440

    Article  PubMed  Google Scholar 

  83. Terpstra AM, Kalkwarf HJ, Shults J, Zemel BS, Wetzsteon RJ, Foster BJ, Strife CF, Foerster DL, Leonard MB (2012) Bone density and cortical structure after pediatric renal transplantation. J Am Soc Nephrol 23:715–726

    Article  CAS  PubMed  Google Scholar 

  84. Thayu M, Leonard MB, Hyams JS, Crandall WV, Kugathasan S, Otley AR, Olson A, Johanns J, Marano CW, Heuschkel RB, Veereman-Wauters G, Griffiths AM, Baldassano RN, Reach Study G (2008) Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn’s disease: results of the REACH study. Clin Gastroenterol Hepatol 6:1378–1384

    Article  CAS  PubMed  Google Scholar 

  85. Thearle M, Horlick M, Bilezikian JP, Levy J, Gertner JM, Levine LS, Harbison M, Berdon W, Oberfield SE (2000) Osteoporosis: an unusual presentation of childhood Crohn’s disease. J Clin Endocrinol Metab 85:2122–2126

    CAS  PubMed  Google Scholar 

  86. Thomas AG, Taylor F, Miller V (1993) Dietary intake and nutritional treatment in childhood Crohn’s disease. J Pediatr Gastroenterol Nutr 17:75–81

    Article  CAS  PubMed  Google Scholar 

  87. Tsampalieros A, Gupta P, Denburg MR, Shults J, Zemel BS, Mostoufi-Moab S, Wetzsteon RJ, Herskovitz RM, Whitehead KM, Leonard MB (2013) Glucocorticoid effects on changes in bone mineral density and cortical structure in childhood nephrotic syndrome. J Bone Miner Res 28:480–488

    Article  CAS  PubMed  Google Scholar 

  88. Tsampalieros A, Lam CK, Spencer JC, Thayu M, Shults J, Zemel BS, Herskovitz RM, Baldassano RN, Leonard MB (2013) Long-term inflammation and glucocorticoid therapy impair skeletal modeling during growth in childhood Crohn disease. J Clin Endocrinol Metab 98(8):3438-3445

    Google Scholar 

  89. Tuchman S, Thayu M, Shults J, Zemel BS, Burnham JM, Leonard MB (2008) Interpretation of biomarkers of bone metabolism in children: impact of growth velocity and body size in healthy children and chronic disease. J Pediatr 153:484–490

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  90. Uno JK, Kolek OI, Hines ER, Xu H, Timmermann BN, Kiela PR, Ghishan FK (2006) The role of tumor necrosis factor alpha in down-regulation of osteoblast Phex gene expression in experimental murine colitis. Gastroenterology 131:497–509

    Article  CAS  PubMed  Google Scholar 

  91. van Coeverden SC, Netelenbos JC, de Ridder CM, Roos JC, Popp-Snijders C, Delemarre-van de Waal HA (2002) Bone metabolism markers and bone mass in healthy pubertal boys and girls. Clin Endocrinol (Oxf) 57:107–116

    Article  Google Scholar 

  92. Varghese S, Wyzga N, Griffiths AM, Sylvester FA (2002) Effects of serum from children with newly diagnosed Crohn disease on primary cultures of rat osteoblasts. J Pediatr Gastroenterol Nutr 35:641–648

    Article  CAS  PubMed  Google Scholar 

  93. Vazquez MA, Lopez E, Montoya MJ, Giner M, Perez-Temprano R, Perez-Cano R (2012) Vertebral fractures in patients with inflammatory bowel disease compared with a healthy population: a prospective case–control study. BMC Gastroenterol 12:47

    Article  PubMed Central  PubMed  Google Scholar 

  94. Viswanathan A, Sylvester FA (2008) Chronic pediatric inflammatory diseases: effects on bone. Rev Endocr Metab Disord 9:107–122

    Article  PubMed  Google Scholar 

  95. Walther F, Fusch C, Radke M, Beckert S, Findeisen A (2006) Osteoporosis in pediatric patients suffering from chronic inflammatory bowel disease with and without steroid treatment. J Pediatr Gastroenterol Nutr 43:42–51

    Article  PubMed  Google Scholar 

  96. Ward LM, Rauch F, Matzinger MA, Benchimol EI, Boland M, Mack DR (2010) Iliac bone histomorphometry in children with newly diagnosed inflammatory bowel disease. Osteoporos Int 21:331–337

    Article  CAS  PubMed  Google Scholar 

  97. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 102:274–282

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  98. Werkstetter KJ, Ullrich J, Schatz SB, Prell C, Koletzko B, Koletzko S (2012) Lean body mass, physical activity and quality of life in paediatric patients with inflammatory bowel disease and in healthy controls. J Crohn’s Colitis 6:665–673

    Article  Google Scholar 

  99. Whitten KE, Leach ST, Bohane TD, Woodhead HJ, Day AS (2010) Effect of exclusive enteral nutrition on bone turnover in children with Crohn’s disease. J Gastroenterol 45:399–405

    Article  CAS  PubMed  Google Scholar 

  100. Wong SC, Khanna S, Rashid R, Ahmed SF (2008) Auditing bone densitometry and fractures in children with chronic disease. Arch Dis Child 93:705–707

    Article  CAS  PubMed  Google Scholar 

  101. Wong SC, Smyth A, McNeill E, Galloway PJ, Hassan K, McGrogan P, Ahmed SF (2010) The growth hormone insulin-like growth factor 1 axis in children and adolescents with inflammatory bowel disease and growth retardation. Clin Endocrinol (Oxf) 73:220–228

    CAS  Google Scholar 

  102. Yang LS, Alex G, Catto-Smith AG (2012) The use of biologic agents in pediatric inflammatory bowel disease. Curr Opin Pediatr 24:609–614

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have no conflict of interests to declare.

Author information

Authors and Affiliations

  1. Department of Endocrinology, The Royal Children’s Hospital, Flemington Road, Parkville, 3052, Melbourne, Australia

    Sze Choong Wong & Margaret Zacharin

  2. Centre for Hormone Research, Murdoch Childrens Research Institute, Melbourne, Australia

    Sze Choong Wong & Margaret Zacharin

  3. Department of Gastroenterology, The Royal Children’s Hospital, Melbourne, Australia

    A. G. Anthony Catto-Smith

  4. Department of Paediatrics, University of Melbourne, Melbourne, Australia

    A. G. Anthony Catto-Smith & Margaret Zacharin

Authors
  1. Sze Choong Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. G. Anthony Catto-Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Margaret Zacharin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Margaret Zacharin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wong, S.C., Catto-Smith, A.G.A. & Zacharin, M. Pathological fractures in paediatric patients with inflammatory bowel disease. Eur J Pediatr 173, 141–151 (2014). https://doi.org/10.1007/s00431-013-2174-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-013-2174-5

Keywords

Search

Navigation